Source: International Congress 2018 – Progress in rare interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Radzikowska (Warsaw, Poland), E. Wiatr (Warsaw, Poland), K. Blasnska-Przerwa (Warsaw, Poland), K. Roszkowski-Sliz (Warsaw, Poland). Chemotherapy in patients with pulmonary Langerhans cell histiocytosis. 3782

Member's Comments

No comment yet.

Related content which might interest you: Pneumothorax in patients with Langerhans cell histiocytosis Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Pulmonary Langerhans cell histiocytosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008 Paediatric pulmonary Langerhans cell histiocytosis Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020 Year: 2020 Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis Source: ERJ Open Res, 4 (1) 00089-2017; 10.1183/23120541.00089-2017 Year: 2018 Lung transplantation for pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Pulmonary Langerhans' cell histiocytosis Source: Eur Respir Mon; 2009: 46: 155–175 Year: 2009 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Effectiveness of chemotherapy treatment for patients with pulmonary Langerhans cell histiocytosis during long-term follow-up Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Multisystemic Langerhans cell histiocytosis unresponsive to aggressive chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 383s Year: 2006 Lung function progression in Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Genetic landscape of pulmonary langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Effectiveness of various therapy regimens for patients with pulmonary Langerhans cell histiocytosis during long-term follow-up Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019